Para las personas que viven con diabetes se les brinda educación en diabetes, se evalua el riesgo de complicaciones y se le ofrece la mejor opción terapéutica incluyendo el abordaje nutricional con el apoyo de mi nutricionista y mi asistente en coaching. Se selecciona el tratamiento óptimo con medicamentos y se recomienda el monitoreo personalizado de la glucosa empleando las herramientas como los glucómetros o los dispositivos novedosos medir la glucosa en los tejidos.

English, Español

• Endocrinologo. Especialista en Endocrinología. Enero 1983 - 1983
• Licenciado en Ciencias de la Salud. Universidad de Costa Rica. 1977

• Sub especialidad post doctoral de Diabetes y Metabolismo de Lípidos - Hospital General de Toronto, Universidad de Toronto. Toronto, Canadá. 1983 - 1986

• Investigador clínico Compañero Universidad de Toronto

• Especialista en Endocrinologia

• Post doctoral Fellow Universidad de Toronto

  Enero 1983 - 1986

• Diabetes Education Universidad de Manitoba

• Colegio de Médicos y Cirujanos de Costa Rica cod. MED1629Activo

  Médico y Cirujano - Costa Rica

• Comité de Certificación Médica del Hospital CIMA

• 2022 Miembro de la Academia Nacional de Medicina
• 2017 Premio AACE International Clinician 2017

• Jefe de Servicio de Endocrinología Hospital CIMA
• Dept de Endocrinología Hospital CIMA
• Profesor de Medicina UCIMED

• Mas de 54 publicaciones en revistas nacionales e internacionales.Revisor de articulos sobre dislipidemia de la Revista: Diabetes Obesidad and Metabolism.
• Ex presidente del Capitulo AACE Costa Rica
• Rosen JB; Jiménez JG; Pirags V; Vides H; Hanson M; Massaad R; McPeters G; Joseph Triscari J; Brudi P. A Comparison of Switching to Ezetimibe/Simvastatin (10 mg/20 mg) versus Doubling the Statin Dose to Simvastatin 40 mg or Atorvastatin 20 mg or Switching to Rosuvastatin 10 mg in Patients with Cardiovascular Disease and Diabetes Mellitus. Diab Vasc Dis Res 2013 Jan 3. Rosen et al. Lipids in Health and Disease 2013, 12:103 http://www.lipidworld.com/content/12/1/103
• Jiménez JG, Rosen JB, Pigras V, Massad R, Handson ME, Brudi P, Triscari J. The efficacy and safety of ezetimebe/simvastatin combination compared with intensified lipid-lowerin treatment strategies in diabetic subjects with and without metabolic syndrome. Diabetes, Obesity and Metabolism 2013;15(6):513-1522.
• Jiménez-Montero JG, Gregory Haft. Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence. Research and Reports in Endocrine Disorders. 2015:5 1–13.
• Gamboa-Gamboa T, Abarca-Soto G, Jiménez-Montero JG. Prevalence of 25-hydroxyvitamin D deficiency in healthy people in the Metropolitan Area in Costa Rica. Research and Reports in Endocrine Disorders. 2015:5 135–140.
• Jiménez.Montero JG Pos-Delivery Hypoglycemia in Type 1 Diabetic Patient is Associated with Lactation: A Case Presentation. http://dx.doi.org/10.18689/MJD1102
• Mechanick JI, Harrel RM, Allende-Vigo M, et al. AACE/ACE Transculturalization Recommendations for Developing Latin American Clinical Practice Algorithms in Endocrinology-Proceedings of the 2015 Pan-American Workshop by the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocrine Practice 2016: 2:476-501.
• Jiménez Montero JG, Cartín Caballero V. Neutropenia severa inducida por propiltiuracilo. AMC 2018; 60:44-46.
• Jiménez-Montero, JG; Mora-Aguilar; Chen-Ku Chih. Diabetic Ketoacidosis in a Patient with Type 1 Diabetes Mellitus Treated with Low Insulin Doses in Combination with Empagliflozin. AACE Clinical Case Rep. 2018;4(No. 6).
• Jiménez-Montero, JG, Moya-Sancho E, Brenes-Pino F, Crespo-Sáenz A, Rivera-Aguerri A. Resistant hypertension in a patient with Primary Aldosteronism due to a suprarenal adenoma. AMC 2019 (No.2, vol 61)
• Jiménez-Montero JG. Diabetic Ketoacidosis Linked with Sodium Glucose Co-Transporter 2 Inhibitors in an Elderly Patient with Type 2 Diabetes. Int J Endocrinol Metab Disord. 2019 5(1): dx.doi.org/10.16966/2380-548X.154
• Jiménez-Montero JG, Hernández-Saborío I, Cob-Sánchez A. Severe Hypoglycemia in an Emergency Department of a General Hospital in Costa Rica. Diabetes & it´s Complications. 2019; 3(2): 1-5.
• Jiménez-Montero JG, Cerdas-Perez S, Ruiz-Salazar F, Yung-Li G, Ulate-Oviedo L, Jiménez-Navarrete M, Calvo-Marin J, Alvayero C and Palencia J. Diabetes Ketoacidosis Linked to Inhibitors of Sodium Glucose Co-Transporters in Diabetic Patients in Central America. Annals of Clinical Diabetes and Endocrinology. 2020; (3):1-5.
• Jimenez-Montero JG, Briceño L. Diabetic Ketoacidosis, Lactic Acidosis and Alcoholic Acidosis in a Type 2 Diabetic Male: Synergic Effects of SGLT-2 Inhibitors with Heavy Alcohol Consumption Int J Clin Med Cases Volume: 3.5 2020.
• Jiménez-Montero JG, Villegas-Barakat M, Cerdas-Salas O. Coto-Hernandez M, Sancho-Ugalde H, MD, Covid-19 in Costa Rica: Achieved goals and imminent risks. Int J Biomed Res Prac, 2020 Volume 1 | Issue 1 | 1 of 4.
• Jiménez-Montero JG, Carvajal-Solorzano ML, Villegas-Barakat M. Reduction of Recurrent Severe Hypoglycemia and Hypoglycemia Unawareness in Type 2 Diabetes by Treatment Modification and Diabetes Education. Diabetes & its Complications 2020; 4(2); 1-7.
• Jiménez-Montero JG, Villegas-Barakat M. Diabetes Mortality in Costa Rica 2007-2017. Diabetes Research and Clinical Practice. 2021;174:108749.
• Villegas-Barakat ML, Jiménez-Montero JG. Análisis provincial de la mortalidad por diabetes en Costa Rica. 2007-2017. Rev ALAD 2021; 110-7.